These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15280009)

  • 1. Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant.
    Asin-Cayuela J; Manas AR; James AM; Smith RA; Murphy MP
    FEBS Lett; 2004 Jul; 571(1-3):9-16. PubMed ID: 15280009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
    Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR
    Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the mitochondria-targeted antioxidant mitoquinone in murine acute pancreatitis.
    Huang W; Cash N; Wen L; Szatmary P; Mukherjee R; Armstrong J; Chvanov M; Tepikin AV; Murphy MP; Sutton R; Criddle DN
    Mediators Inflamm; 2015; 2015():901780. PubMed ID: 25878403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity and Mitochondrial Effects of Phenolic and Quinone-Based Mitochondria-Targeted and Untargeted Antioxidants on Human Neuronal and Hepatic Cell Lines: A Comparative Analysis.
    Fernandes C; Videira AJC; Veloso CD; Benfeito S; Soares P; Martins JD; Gonçalves B; Duarte JFS; Santos AMS; Oliveira PJ; Borges F; Teixeira J; Silva FSG
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The targeted anti-oxidant MitoQ causes mitochondrial swelling and depolarization in kidney tissue.
    Gottwald EM; Duss M; Bugarski M; Haenni D; Schuh CD; Landau EM; Hall AM
    Physiol Rep; 2018 Apr; 6(7):e13667. PubMed ID: 29611340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-crippled MitoQ potently inhibits breast cancer and glioma cell proliferation: A negative control for verifying the antioxidant mechanism of MitoQ in cancer and other oxidative pathologies.
    Cheng G; Karoui H; Hardy M; Kalyanaraman B
    Free Radic Biol Med; 2023 Aug; 205():175-187. PubMed ID: 37321281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MitoQ as an antenatal antioxidant treatment improves markers of lung maturation in healthy and hypoxic pregnancy.
    Lock MC; Botting KJ; Allison BJ; Niu Y; Ford SG; Murphy MP; Orgeig S; Giussani DA; Morrison JL
    J Physiol; 2023 Aug; 601(16):3647-3665. PubMed ID: 37467062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of myocardial patches and intramyocardial injections in treating myocardial infarction with a MitoQ/hydrogel system.
    Tan Y; Nie Y; ZhengWen L; Zheng Z
    J Mater Chem B; 2024 Jun; 12(24):5838-5847. PubMed ID: 38771306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19.
    Ouyang L; Gong J
    Med Hypotheses; 2020 Nov; 144():110161. PubMed ID: 32795832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
    Zielonka J; Joseph J; Sikora A; Hardy M; Ouari O; Vasquez-Vivar J; Cheng G; Lopez M; Kalyanaraman B
    Chem Rev; 2017 Aug; 117(15):10043-10120. PubMed ID: 28654243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating a Polyethyleneglycol Linker to Enhance the Hydrophilicity of Mitochondria-Targeted Triphenylphosphonium Constructs.
    Uno S; Harkiss AH; Chowdhury R; Caldwell ST; Prime TA; James AM; Gallagher B; Prudent J; Hartley RC; Murphy MP
    Chembiochem; 2023 Jun; 24(11):e202200774. PubMed ID: 36917207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of Cytotoxic and Antimicrobial Effects of Triphenylphosphonium Conjugates with Various Quinone Derivatives.
    Nazarov PA; Zinovkina LA; Brezgunova AA; Lyamzaev KG; Golovin AV; Karakozova MV; Kotova EA; Plotnikov EY; Zinovkin RA; Skulachev MV; Antonenko YN
    Biochemistry (Mosc); 2024 Feb; 89(2):212-222. PubMed ID: 38622091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed cell death in plants: protective effect of mitochondrial-targeted quinones.
    Vasil'ev LA; Dzyubinskaya EV; Kiselevsky DB; Shestak AA; Samuilov VD
    Biochemistry (Mosc); 2011 Oct; 76(10):1120-30. PubMed ID: 22098237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MitoQ--a mitochondria-targeted antioxidant.
    Tauskela JS
    IDrugs; 2007 Jun; 10(6):399-412. PubMed ID: 17642004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting antioxidants to mitochondria by conjugation to lipophilic cations.
    Murphy MP; Smith RA
    Annu Rev Pharmacol Toxicol; 2007; 47():629-56. PubMed ID: 17014364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools.
    James AM; Cochemé HM; Smith RA; Murphy MP
    J Biol Chem; 2005 Jun; 280(22):21295-312. PubMed ID: 15788391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal and human studies with the mitochondria-targeted antioxidant MitoQ.
    Smith RA; Murphy MP
    Ann N Y Acad Sci; 2010 Jul; 1201():96-103. PubMed ID: 20649545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrially targeted compounds and their impact on cellular bioenergetics.
    Reily C; Mitchell T; Chacko BK; Benavides G; Murphy MP; Darley-Usmar V
    Redox Biol; 2013; 1(1):86-93. PubMed ID: 23667828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases.
    James AM; Sharpley MS; Manas AR; Frerman FE; Hirst J; Smith RA; Murphy MP
    J Biol Chem; 2007 May; 282(20):14708-18. PubMed ID: 17369262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults.
    Rossman MJ; Santos-Parker JR; Steward CAC; Bispham NZ; Cuevas LM; Rosenberg HL; Woodward KA; Chonchol M; Gioscia-Ryan RA; Murphy MP; Seals DR
    Hypertension; 2018 Jun; 71(6):1056-1063. PubMed ID: 29661838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.